[8-K] SANUWAVE Health, Inc. Reports Material Event

Rhea-AI Filing Summary

ReTo Eco-Solutions, Inc. (RETO) filed a second amendment to its April 25 2025 Form 6-K to add the consent of its independent auditor, Wei, Wei & Co., LLP (Exhibit 23.1). The original 6-K and first amendment had disclosed and provided financials for ReTo’s acquisition of 5,100 ordinary shares of MeinMalzeBier Holdings Limited, completed the same day. No financial statements, pro-forma data, or transaction terms have been revised; the sole purpose of this filing is to supply the auditor’s consent so that the earlier financial information can be incorporated by reference into ReTo’s effective registration statements on Forms F-3 (File Nos. 333-267101 & 333-282314) and S-8 (File Nos. 333-270355 & 333-280119). The amendment is purely administrative and does not introduce new operational or financial developments.

Insights

Corporate Governance Analyst

TL;DR: Neutral, administrative 6-K/A only adds auditor consent; no financial impact.

This 6-K/A is a housekeeping item. Adding Wei, Wei & Co., LLP’s consent ensures that previously issued audited financials related to the MeinMalzeBier share exchange remain valid for pending F-3 and S-8 offerings. Because neither financial figures nor deal terms change, the filing has no direct valuation or cash-flow implications. Investors should view the amendment as compliance-driven, not a signal of operating performance or strategic shift.

FALSE000141766300014176632025-07-282025-07-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) July 28, 2025

SANUWAVE Health, Inc.

(Exact name of registrant as specified in its charter)

Nevada			001-42552			20-1176000
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

11495 Valley View Road,			Eden Prairie,			Minnesota			55344
(Address of principal executive offices)									(Zip Code)

Registrant’s telephone number, including area code (952) 656-1029

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, par value $0.001 per share			SNWV			The Nasdaq Stock Market LLC

Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

1

Item 5.02              Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As previously disclosed, on May 30, 2025, Nanci Gilmore, the former Chief Commercial Officer of Sanuwave Health, Inc. (the “Company”), was terminated without cause, effective as of the same date. On July 28, 2025, Ms. Gilmore and the Company entered into a Separation and Release Agreement (the “Separation Agreement”), pursuant to which Ms. Gilmore will receive a lump sum cash payment of (i) five months’ annual base salary in the amount of $97,916.70 and (ii) a pro-rated bonus in the amount of $14,790.81, in each case, less applicable federal and state taxes. In addition, the Separation Agreement provides that Ms. Gilmore’s employee stock options will continue to vest through January 31, 2026 and shall remain outstanding and exercisable until their respective expiration dates. The Severance Agreement also includes a release of claims in favor of the Company and customary confidentiality and non-disparagement provisions.

The foregoing description of the Separation Agreement does not purport to be complete and is qualified by reference to the full text of the Separation Agreement, which is filed hereto as Exhibit 10.1 and is incorporated herein by reference.

Item 9.01              Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No.						Description
10.1						Separation and Release Agreement, dated July 28, 2025, between Nanci Gilmore and the Company.
104						Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			SANUWAVE HEALTH, INC.
Dated: July 31, 2025			By:			/s/ Morgan C. Frank
			Name:			Morgan C. Frank
			Title:			Chief Executive Officer

3

FAQ

Why did RETO file an amended Form 6-K/A on 31 July 2025?

To attach Wei, Wei & Co., LLP’s consent (Exhibit 23.1) to the previously filed 6-K covering the MeinMalzeBier share exchange.

Does this amendment change any financial statements for ReTo Eco-Solutions (RETO)?

No. The filing expressly states that only the auditor consent is new; all prior financial data remain unchanged.

What exhibit was added in the 6-K/A?

Exhibit 23.1, the consent of independent registered public accounting firm Wei, Wei & Co., LLP.

Are ReTo’s registration statements affected by this filing?

Yes. The consent is incorporated by reference into ReTo’s active F-3 and S-8 registration statements to keep them current.

When did the MeinMalzeBier share exchange close?

The transaction closed on 25 April 2025, the same day the original Form 6-K was filed.